Meseclazone (W-2395; NSC297623) is a nonsteroidal anti-inflammatory drug (NSAID) with anti-inflammatory, analgesic, and antipyretic activities; it inhibits collagen-induced platelet aggregation in vivo and exhibits dose-dependent inhibition of bronchoconstriction.